Goldman Sachs estimates that this new “Future Fuel” will unleash an $11.7 trillion wave of wealth over the coming decade. That’s 10 TIMES BIGGER than the electric vehicle market.

QPT Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 17.12%

Insider Buying (Last 12 Months): C$4,570.30

Insider Selling (Last 12 Months): C$0.00

Quest PharmaTech Insider Trading History Chart

Quest PharmaTech Share Price & Price History

C^$0.02

▼ -0.01 (-33.33%)

As of 05/3/2024 06:43 PM ET

Days: 30 | 90 | 365

Make this ONE trade on Tuesday at 2 p.m. EST!

From Monument Traders Alliance | Ad

Every time the U.S. Government releases jobs, inflation, GDP and other Economic Reports… Use The JOLTS Loophole to target up to 253%... 327%... Even 383% Overnight Profits!

Discover The Secret Loophole BEFORE Tuesday!

Quest PharmaTech Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
9/15/2023	Ragupathy Madiyalakan	Director	Buy	15,290	C$0.07	C$1,070.30
8/29/2023	Ragupathy Madiyalakan	Director	Buy	30,000	C$0.07	C$2,100.00
8/25/2023	Ragupathy Madiyalakan	Director	Buy	20,000	C$0.07	C$1,400.00

No experience to confident trader, meet my student…

From Wealth Builders Institute | Ad

Uncover the secrets to stress-free trading and discover how you can start seeing profits without the steep learning curve.

Click here

SEC Filings (Institutional Ownership Changes) for Quest PharmaTech (CVE:QPT)

Quest PharmaTech Inc., a pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer. Its lead product candidate is Mab AR 9.6 against truncated O-glycan on MUC16, for targeted cancer therapy applications. The company also offers Oregovomab, which is in Phase III clinical trial for the treatment of ovarian cancer. In addition, it develops, manufactures, and commercializes immunotherapy products for pancreatic cancer; and combinatorial immunotherapeutic products for the treatment cancer by using monoclonal antibodies of the immunoglobulin of G and E class. Quest PharmaTech Inc. is headquartered in Edmonton, Canada.

Today's Range

Now: C$0.02

C$0.02

50 Day Range

MA: C$0.03

C$0.02

C$0.04

52 Week Range

Now: C$0.02

C$0.02

C$0.11

Volume

14,000 shs

Average Volume

48,153 shs

Market Capitalization

C$3.38 million

P/E Ratio

N/A

Dividend Yield

6.15%

Beta

0.29

Who are the company insiders with the largest holdings of Quest PharmaTech?: Quest PharmaTech's top insider shareholders include:
Ragupathy Madiyalakan (Director)
Learn More about top insider investors at Quest PharmaTech.